What will Canopy Growth's share price be in 2019?
Their forecasts range from C$7.00 to C$45.00. On average, they expect Canopy Growth's share price to reach C$19.08 in the next year. This suggests a possible upside of 81.2% from the stock's current price. View analysts' price targets for Canopy Growth or view top-rated stocks among Wall Street analysts. Who are Canopy Growth's key executives?
What is the upside for Canopy Growth's Stock?
Their forecasts range from C$25.00 to C$75.00. On average, they anticipate Canopy Growth's share price to reach C$57.20 in the next year. This suggests a possible upside of 102.0% from the stock's current price. View Analyst Price Targets for Canopy Growth.
What price target do analysts set for Canopy Growth Corporation (CGC)?
What price target have analysts set for CGC? 17 equities research analysts have issued twelve-month price objectives for Canopy Growth's shares. Their forecasts range from $7.00 to $55.00. On average, they anticipate Canopy Growth's stock price to reach $22.33 in the next twelve months.
What is the earnings forecast for Canopy Growth Inc (weed)?
Canopy Growth is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022. View our earnings forecast for Canopy Growth. What price target have analysts set for WEED? 14 analysts have issued 1 year target prices for Canopy Growth's shares. Their forecasts range from C$7.00 to C$45.00.
See more
Is Canopy Growth a buy sell or hold?
Canopy Growth has received a consensus rating of Hold. The company's average rating score is 1.59, and is based on 2 buy ratings, 6 hold ratings, and 9 sell ratings.
Should I buy Cgsi stock?
If you are looking for stocks with good return, CGS International Inc can be a profitable investment option. CGS International Inc quote is equal to 0.126 USD at 2022-07-22. Based on our forecasts, a long-term increase is expected, the "CGSI" stock price prognosis for 2027-07-19 is 7.647 USD.
Will CGC split?
Canopy Growth (CGC) has 1 split in our Canopy Growth stock split history database. The split for CGC took place on December 21, 1993. This was a 3 for 2 split, meaning for each 2 shares of CGC owned pre-split, the shareholder now owned 3 shares....CGC Split History TableDateRatio12/21/19933 for 2
Is canopy growth a buy Zacks?
The Zacks database contains over 10,000 stocks. All of those stocks are classified into three groups: Sector, M Industry and X Industry....Momentum Scorecard. More Info.Zacks RankDefinitionAnnualized Return1Strong Buy24.75%2Buy18.15%3Hold9.70%4Sell5.35%2 more rows
Is CGI a good stock to buy?
The 12 analysts offering 12-month price forecasts for CGI Inc have a median target of 93.63, with a high estimate of 105.52 and a low estimate of 82.49. The median estimate represents a +11.27% increase from the last price of 84.15.
Who is CGSI stock?
(CGSI) Stock Price, News, Quote & History - Yahoo Finance....Performance Outlook.Previous Close0.105052 Week Range0.0050 - 26.0000Volume422,953Avg. Volume397,2114 more rows
Should I keep Canopy Growth stock?
Is Canopy Growth Stock A Buy? Bottom line: Canopy Growth stock is not in a buy zone, so it isn't a buy right now. IBD's research shows investors would be better off looking for stocks with stronger fundamentals and that are closer to their highs.
Will constellation buy Canopy Growth?
Constellation agreed to acquire between 21.93 million or 5.4% of Canopy stock and 30.7 million shares or 7.6% of Canopy stock that will convert from debt.
Is a stock split good?
Stock splits are generally a sign that a company is doing well, meaning it could be a good investment. Additionally, because the per-share price is lower, they're more affordable and you can potentially buy more shares.
Should I buy Guardion Health Sciences stock?
Is Guardion Health Sciences Stock a good buy in 2022, according to Wall Street analysts? The consensus among 2 Wall Street analysts covering (NASDAQ: GHSI) stock is to Strong Buy GHSI stock.
Is Guardion Health Sciences a buy?
Guardion Health Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Should I buy or sell Canopy Growth stock right now?
15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are curr...
What is Canopy Growth's stock price forecast for 2022?
15 Wall Street research analysts have issued 12-month price objectives for Canopy Growth's shares. Their CGC stock forecasts range from $3.50 to $2...
How has Canopy Growth's stock price performed in 2022?
Canopy Growth's stock was trading at $8.73 at the beginning of 2022. Since then, CGC shares have decreased by 58.2% and is now trading at $3.65. V...
When is Canopy Growth's next earnings date?
Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Canopy G...
How were Canopy Growth's earnings last quarter?
Canopy Growth Co. (NASDAQ:CGC) announced its quarterly earnings results on Friday, May, 27th. The company reported ($1.46) earnings per share (EPS)...
Who are Canopy Growth's key executives?
Canopy Growth's management team includes the following people: Mr. David Eric Klein , CEO & Director (Age 58, Pay $2.79M) Mr. Julious C. Grant J...
Who are some of Canopy Growth's key competitors?
Some companies that are related to Canopy Growth include Tilray (TLRY) , USANA Health Sciences (USNA) , Cronos Group (CRON) , Cresco Labs (CRLB...
What is Canopy Growth's stock symbol?
Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."
Who are Canopy Growth's major shareholders?
Canopy Growth's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.00%...
Is CANOPY GROWTH Stock a good buy in 2022, according to Wall Street analysts?
The consensus among 7 Wall Street analysts covering ( NASDAQ : CGC ) stock is to Sell CGC stock. Out of 7 analysts , 0 ( 0% ) are recomme...
What is CGC's earnings growth forecast for 2023-2025?
( NASDAQ : CGC ) CANOPY GROWTH 's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty...
What is CGC's revenue growth forecast for 2023-2025?
( NASDAQ : CGC ) CANOPY GROWTH 's forecast annual revenue growth rate of 23.39% is forecast to beat the US Drug Manufacturers - Specialty & G...
What is CGC's forecast return on assets (ROA) for 2023-2025?
(NASDAQ: CGC) forecast ROA is -2.66%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 17.57%.
What is CGC's Price Target?
According to 5 Wall Street analyst s that have issued a 1 year CGC price target, the average CGC price target is $7.30 , with the highest C...
What is CGC's Earnings Per Share (EPS) forecast for 2023-2025?
(NASDAQ: CGC) CANOPY GROWTH's current Earnings Per Share (EPS) is -$0.60. On average, analysts forecast that CGC's EPS will be -$0.71 for 2023, wit...
What is CGC's forecast return on equity (ROE) for 2023-2025?
(NASDAQ: CGC) forecast ROE is -4.17%, which is considered weak.
About Canopy Growth
Canopy Growth (NASDAQ:CGC) Frequently Asked Questions
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products.
Analyst price target for CGC
12 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last year. There are currently 5 sell ratings, 6 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Canopy Growth stock.
CGC earnings per share forecast
Based on 6 analyst s offering 12 month price targets for Canopy Growth Corp.
CGC revenue forecast
What is CGC 's earnings per share in the next 3 years based on estimates from 8 analyst s?
CGC revenue growth forecast
What is CGC 's revenue in the next 3 years based on estimates from 5 analyst s?
Historical and forecast chart of Canopy Growth stock
How is CGC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Canopy Growth Daily Price Targets
The chart below shows the historical price of Canopy Growth stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Canopy Growth stock price can be found in the table below.
Canopy Growth forecast for this year
Forecast target price for 02-25-2022: $ 7.19. Positive dynamics for Canopy Growth shares will prevail with possible volatility of 3.725%.
Canopy Growth information and performance
An uptrend is forecast for this month with an optimal target price of $ 7.9079. Pessimistic: $7.14. Optimistic: $8.60
About Canopy Growth
The Canopy Growth Corporation, together with its subsidiaries, manufactures, distributes and markets cannabis for recreational and medical purposes, primarily in Canada, the United States, Germany and the United Kingdom. It operates in two segments: cannabis, hemp and other consumer products; and hinged rivers.
Headlines
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps.
Canopy Growth (TSE:WEED) Frequently Asked Questions
Óskare Capital is raising $170 million to chase down medical cannabis deals. Its top partner explains why Europe is an untapped market.
Signals & Forecast
12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are currently 5 sell ratings, 4 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" Canopy Growth stock.
Support, Risk & Stop-loss
A buy signal was issued from a pivot bottom point on Thursday, January 27, 2022, and so far it has risen 4.53%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning.
Is Canopy Growth Corporation stock A Buy?
Canopy Growth Corporation finds support from accumulated volume at $7.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
Insiders are positive buying more shares than they are selling in Canopy Growth Corporation
Canopy Growth Corporation holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.
Golden Star Signal
In the last 56 trades there were 20.19 million shares bought and 10.03 million shares sold. The last trade was done 57 days ago by Lazzarato David Angelo who sold 672 shares. The large amount of stocks bought compared to stocks sold indicate that the insiders believe there is a potential good upside.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Canopy Growth Corp Stock Forecast
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
Will Canopy Growth Corp Stock Go Up Next Year?
Over the next 52 weeks, Canopy Growth Corp has on average historically risen by 80.3 % based on the past 7 years of stock performance.
Canopy Growth Corp Stock Price History
Over the next 52 weeks, Canopy Growth Corp has on average historically risen by 80.3% based on the past 7 years of stock performance.
Stock Predictions
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CGC is experiencing selling pressure, which indicates risk of future bearish movement.
What is canopy growth?
Is Canopy Growth Corp stock public? Yes, Canopy Growth Corp is a publicly traded company.
What is global cannabis?
Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Historical and forecast chart of Canopy Growth stock
The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits.
Canopy Growth information and performance
The chart below shows the historical price of Canopy Growth stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Canopy Growth stock price can be found in the table below.
Canopy Growth price target for 2021 by month
The Canopy Growth Corporation, together with its subsidiaries, manufactures, distributes and markets cannabis for recreational and medical purposes, primarily in Canada, the United States, Germany and the United Kingdom. It operates in two segments: cannabis, hemp and other consumer products; and hinged rivers.
